Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.9% |
| 2 | Healthcare | 14.3% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.98% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPIC
1601
DELISTED
TPI Composites
TPIC
| $3.92M | ﹤0.01% |
69,400
+1,500
| +2% | +$90.2K |
|
1602
Century Communities
CCS
$2B
| $3.91M | ﹤0.01% |
64,766
+600
| +0.9% | +$32.6K |
|
1603
Otter Tail
OTTR
$3.87B
| $3.9M | ﹤0.01% |
84,500
+1,300
| +2% | +$55.6K |
|
1604
Burford Capital
BUR
$968M
| $3.9M | ﹤0.01% |
450,414
+3,595
| +0.8% | +$31.5K |
|
|
ENDP
1605
DELISTED
Endo International plc
ENDP
| $3.9M | ﹤0.01% |
526,200
+5,600
| +1% | +$45.4K |
|
1606
Goosehead Insurance
GSHD
$2.33B
| $3.89M | ﹤0.01% |
36,300
+1,200
| +3% | +$162K |
|
1607
MacroGenics
MGNX
$259M
| $3.89M | ﹤0.01% |
122,000
+5,800
| +5% | +$141K |
|
1608
Ironwood Pharmaceuticals
IRWD
$674M
| $3.88M | ﹤0.01% |
347,500
+4,300
| +1% | +$45.4K |
|
1609
M/I Homes
MHO
$3.82B
| $3.88M | ﹤0.01% |
65,700
+1,100
| +2% | +$57.1K |
|
1610
eHealth
EHTH
$38.8M
| $3.88M | ﹤0.01% |
53,300
+900
| +2% | +$57.5K |
|
1611
CBIZ
CBZ
$2.96B
| $3.87M | ﹤0.01% |
118,400
+1,100
| +0.9% | +$32.4K |
|
1612
PRA Group
PRAA
$762M
| $3.86M | ﹤0.01% |
104,200
+1,000
| +1% | +$36.4K |
|
1613
HNI Corp
HNI
$3.55B
| $3.86M | ﹤0.01% |
97,600
+900
| +0.9% | +$33K |
|
|
ADAM
1614
Adamas Trust
ADAM
$913M
| $3.86M | ﹤0.01% |
215,780
+1,900
| +0.9% | +$31.3K |
|
1615
Westamerica Bancorp
WABC
$1.38B
| $3.85M | ﹤0.01% |
61,400
+300
| +0.5% | +$18.3K |
|
1616
Mercury Insurance
MCY
$5.84B
| $3.85M | ﹤0.01% |
63,300
+600
| +1% | +$34.3K |
|
|
DEA
1617
Easterly Government Properties
DEA
$1.16B
| $3.85M | ﹤0.01% |
74,244
+2,160
| +3% | +$119K |
|
1618
SelectQuote
SLQT
$126M
| $3.84M | ﹤0.01% |
130,100
+56,600
| +77% | +$1.48M |
|
1619
Genworth Financial
GNW
$3.79B
| $3.83M | ﹤0.01% |
1,155,186
+10,300
| +0.9% | +$33.9K |
|
1620
Plains GP Holdings
PAGP
$5.04B
| $3.83M | ﹤0.01% |
407,534
+10,800
| +3% | +$101K |
|
|
INFN
1621
DELISTED
Infinera Corporation Common Stock
INFN
| $3.82M | ﹤0.01% |
397,100
+15,900
| +4% | +$156K |
|
|
RVNC
1622
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.82M | ﹤0.01% |
136,750
+2,600
| +2% | +$71.9K |
|
|
HTLF
1623
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.81M | ﹤0.01% |
75,900
+800
| +1% | +$37.6K |
|
|
GWB
1624
DELISTED
Great Western Bancorp, Inc.
GWB
| $3.81M | ﹤0.01% |
125,700
+1,300
| +1% | +$35.4K |
|
1625
Enpro
NPO
$7.12B
| $3.8M | ﹤0.01% |
44,600
+500
| +1% | +$40.8K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.